List of Tables
Table 1. Global PDE3×PDE4 Inhibitors Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global PDE3×PDE4 Inhibitors Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global PDE3×PDE4 Inhibitors Market Competitive Situation by Manufacturers in 2025
Table 4. Global PDE3×PDE4 Inhibitors Sales (kg) of Key Manufacturers (2021–2026)
Table 5. Global PDE3×PDE4 Inhibitors Sales Market Share by Manufacturers (2021–2026)
Table 6. Global PDE3×PDE4 Inhibitors Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global PDE3×PDE4 Inhibitors Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market PDE3×PDE4 Inhibitors Average Price (US$/g) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of PDE3×PDE4 Inhibitors, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of PDE3×PDE4 Inhibitors, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of PDE3×PDE4 Inhibitors, Product Types and Applications
Table 12. Global Key Manufacturers of PDE3×PDE4 Inhibitors, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PDE3×PDE4 Inhibitors Companies by Tier (Tier 1, Tier 2, Tier 3), based on PDE3×PDE4 Inhibitors Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PDE3×PDE4 Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global PDE3×PDE4 Inhibitors Sales by Region (kg), 2021–2026
Table 18. Global PDE3×PDE4 Inhibitors Sales Market Share by Region (2021–2026)
Table 19. Global PDE3×PDE4 Inhibitors Sales by Region (kg), 2027–2032
Table 20. Global PDE3×PDE4 Inhibitors Sales Market Share by Region (2027–2032)
Table 21. Global PDE3×PDE4 Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 22. Global PDE3×PDE4 Inhibitors Revenue Market Share by Region (2021–2026)
Table 23. Global PDE3×PDE4 Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 24. Global PDE3×PDE4 Inhibitors Revenue Market Share by Region (2027–2032)
Table 25. North America PDE3×PDE4 Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America PDE3×PDE4 Inhibitors Sales by Country (kg), 2021–2026
Table 27. North America PDE3×PDE4 Inhibitors Sales by Country (kg), 2027–2032
Table 28. North America PDE3×PDE4 Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 29. North America PDE3×PDE4 Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 30. Europe PDE3×PDE4 Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe PDE3×PDE4 Inhibitors Sales by Country (kg), 2021–2026
Table 32. Europe PDE3×PDE4 Inhibitors Sales by Country (kg), 2027–2032
Table 33. Europe PDE3×PDE4 Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 34. Europe PDE3×PDE4 Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific PDE3×PDE4 Inhibitors Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific PDE3×PDE4 Inhibitors Sales by Region (kg), 2021–2026
Table 37. Asia Pacific PDE3×PDE4 Inhibitors Sales by Region (kg), 2027–2032
Table 38. Asia Pacific PDE3×PDE4 Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific PDE3×PDE4 Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America PDE3×PDE4 Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America PDE3×PDE4 Inhibitors Sales by Country (kg), 2021–2026
Table 42. Latin America PDE3×PDE4 Inhibitors Sales by Country (kg), 2027–2032
Table 43. Latin America PDE3×PDE4 Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America PDE3×PDE4 Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa PDE3×PDE4 Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa PDE3×PDE4 Inhibitors Sales by Country (kg), 2021–2026
Table 47. Middle East and Africa PDE3×PDE4 Inhibitors Sales by Country (kg), 2027–2032
Table 48. Middle East and Africa PDE3×PDE4 Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa PDE3×PDE4 Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 50. Global PDE3×PDE4 Inhibitors Sales (kg) by Type (2021–2026)
Table 51. Global PDE3×PDE4 Inhibitors Sales (kg) by Type (2027–2032)
Table 52. Global PDE3×PDE4 Inhibitors Sales Market Share by Type (2021–2026)
Table 53. Global PDE3×PDE4 Inhibitors Sales Market Share by Type (2027–2032)
Table 54. Global PDE3×PDE4 Inhibitors Revenue (US$ Million) by Type (2021–2026)
Table 55. Global PDE3×PDE4 Inhibitors Revenue (US$ Million) by Type (2027–2032)
Table 56. Global PDE3×PDE4 Inhibitors Revenue Market Share by Type (2021–2026)
Table 57. Global PDE3×PDE4 Inhibitors Revenue Market Share by Type (2027–2032)
Table 58. Global PDE3×PDE4 Inhibitors Price (US$/g) by Type (2021–2026)
Table 59. Global PDE3×PDE4 Inhibitors Price (US$/g) by Type (2027–2032)
Table 60. Global PDE3×PDE4 Inhibitors Sales (kg) by Application (2021–2026)
Table 61. Global PDE3×PDE4 Inhibitors Sales (kg) by Application (2027–2032)
Table 62. Global PDE3×PDE4 Inhibitors Sales Market Share by Application (2021–2026)
Table 63. Global PDE3×PDE4 Inhibitors Sales Market Share by Application (2027–2032)
Table 64. Global PDE3×PDE4 Inhibitors Revenue (US$ Million) by Application (2021–2026)
Table 65. Global PDE3×PDE4 Inhibitors Revenue (US$ Million) by Application (2027–2032)
Table 66. Global PDE3×PDE4 Inhibitors Revenue Market Share by Application (2021–2026)
Table 67. Global PDE3×PDE4 Inhibitors Revenue Market Share by Application (2027–2032)
Table 68. Global PDE3×PDE4 Inhibitors Price (US$/g) by Application (2021–2026)
Table 69. Global PDE3×PDE4 Inhibitors Price (US$/g) by Application (2027–2032)
Table 70. Verona Pharma plc Company Information
Table 71. Verona Pharma plc Description and Business Overview
Table 72. Verona Pharma plc PDE3×PDE4 Inhibitors Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 73. Verona Pharma plc PDE3×PDE4 Inhibitors Product
Table 74. Verona Pharma plc Recent Developments/Updates
Table 75. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Company Information
Table 76. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 77. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. PDE3×PDE4 Inhibitors Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 78. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. PDE3×PDE4 Inhibitors Product
Table 79. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 80. Haisco Pharmaceutical Group Co., Ltd. Company Information
Table 81. Haisco Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 82. Haisco Pharmaceutical Group Co., Ltd. PDE3×PDE4 Inhibitors Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 83. Haisco Pharmaceutical Group Co., Ltd. PDE3×PDE4 Inhibitors Product
Table 84. Haisco Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 85. Guangdong Hengrui Pharmaceutical Co., Ltd. Company Information
Table 86. Guangdong Hengrui Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Guangdong Hengrui Pharmaceutical Co., Ltd. PDE3×PDE4 Inhibitors Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 88. Guangdong Hengrui Pharmaceutical Co., Ltd. PDE3×PDE4 Inhibitors Product
Table 89. Guangdong Hengrui Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. PDE3×PDE4 Inhibitors Distributors List
Table 93. PDE3×PDE4 Inhibitors Customers List
Table 94. PDE3×PDE4 Inhibitors Market Trends
Table 95. PDE3×PDE4 Inhibitors Market Drivers
Table 96. PDE3×PDE4 Inhibitors Market Challenges
Table 97. PDE3×PDE4 Inhibitors Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of PDE3×PDE4 Inhibitors
Figure 2. Global PDE3×PDE4 Inhibitors Market Value by Type (US$ Million), 2021–2032
Figure 3. Global PDE3×PDE4 Inhibitors Market Share by Type: 2025 & 2032
Figure 4. 2.5mL:2.5g Product Picture
Figure 5. 3mL:3mg Product Picture
Figure 6. Global PDE3×PDE4 Inhibitors Market Value by Application (US$ Million), 2021–2032
Figure 7. Global PDE3×PDE4 Inhibitors Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global PDE3×PDE4 Inhibitors Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global PDE3×PDE4 Inhibitors Market Size (US$ Million), 2021–2032
Figure 13. Global PDE3×PDE4 Inhibitors Sales (kg), 2021–2032
Figure 14. Global PDE3×PDE4 Inhibitors Average Price (US$/g), 2021–2032
Figure 15. PDE3×PDE4 Inhibitors Report Years Considered
Figure 16. PDE3×PDE4 Inhibitors Sales Share by Manufacturers in 2025
Figure 17. Global PDE3×PDE4 Inhibitors Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global PDE3×PDE4 Inhibitors Players: Market Share by Revenue in PDE3×PDE4 Inhibitors in 2025
Figure 19. PDE3×PDE4 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global PDE3×PDE4 Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America PDE3×PDE4 Inhibitors Sales Market Share by Country (2021–2032)
Figure 22. North America PDE3×PDE4 Inhibitors Revenue Market Share by Country (2021–2032)
Figure 23. United States PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe PDE3×PDE4 Inhibitors Sales Market Share by Country (2021–2032)
Figure 26. Europe PDE3×PDE4 Inhibitors Revenue Market Share by Country (2021–2032)
Figure 27. Germany PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific PDE3×PDE4 Inhibitors Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific PDE3×PDE4 Inhibitors Revenue Market Share by Region (2021–2032)
Figure 34. China PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America PDE3×PDE4 Inhibitors Sales Market Share by Country (2021–2032)
Figure 42. Latin America PDE3×PDE4 Inhibitors Revenue Market Share by Country (2021–2032)
Figure 43. Mexico PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa PDE3×PDE4 Inhibitors Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa PDE3×PDE4 Inhibitors Revenue Market Share by Country (2021–2032)
Figure 49. Turkey PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE PDE3×PDE4 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of PDE3×PDE4 Inhibitors by Type (2021–2032)
Figure 53. Global Revenue Market Share of PDE3×PDE4 Inhibitors by Type (2021–2032)
Figure 54. Global PDE3×PDE4 Inhibitors Price (US$/g) by Type (2021–2032)
Figure 55. Global Sales Market Share of PDE3×PDE4 Inhibitors by Application (2021–2032)
Figure 56. Global Revenue Market Share of PDE3×PDE4 Inhibitors by Application (2021–2032)
Figure 57. Global PDE3×PDE4 Inhibitors Price (US$/g) by Application (2021–2032)
Figure 58. PDE3×PDE4 Inhibitors Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
